Evaluation and treatment of hypercalcemia.
Mundy
G R
GR
Division of Endocrinology and Metabolism, University of Texas Health Science Center, San Antonio.
D000236:Adenoma / Q000150:complications / Q000601:surgery; D000368:Aged; D001859:Bone Neoplasms / Q000150:complications / Q000556:secondary; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000556:secondary; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000008:administration & dosage; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D006961:Hyperparathyroidism / Q000150:complications / Q000175:diagnosis; D007262:Infusions, Intravenous; D008175:Lung Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D000077268:Pamidronate; D010282:Parathyroid Neoplasms / Q000150:complications / Q000175:diagnosis / Q000601:surgery; D012965:Sodium Chloride / Q000627:therapeutic use
D004164:Diphosphonates; D012965:Sodium Chloride; D000077268:Pamidronate